Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1472471

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1472471

North America Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The North America Cellulite Treatment Market would witness market growth of 9.5% CAGR during the forecast period (2024-2031).

The US market dominated the North America Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,828.3 Million by 2031. The Canada market is experiencing a CAGR of 10% during (2024 - 2031). Additionally, The Mexico market would experience a CAGR of 10.5% during (2024 - 2031).

Cellulite, often described as the dimpled or lumpy appearance of the skin, affects a large percentage of the population, particularly women, and is commonly found on the thighs, hips, buttocks, and abdomen. Although cellulite does not pose any health risks, it can significantly impair an individual's self-esteem and body image, prompting considerable interest in exploring treatment alternatives.

According to the National Library of Medicine, very little is known about the prevalence and incidence of cellulite and the predisposing factors for cellulite development because of a lack of robust epidemiologic data. Despite this shortcoming, it is widely reported in the literature that an estimated 80% to 90% of postpubertal females are affected by this condition. There is no particular age of onset for cellulite. It can occur at any age postpuberty, although it mostly appears between the ages of 20 and 30. Males are rarely affected by cellulite. In about 2% of males, cellulite may develop due to androgen deficiency secondary to castration, hypogonadism, Klinefelter's syndrome, or estrogen or antiandrogen therapy for prostate cancer.

The increasing demand for cellulite treatment in the US can be linked to the significant growth in the older population. The US Census Bureau estimates that between 1920 and 2020, the population over 65 grew by 50.9 million, or nearly five times the overall population growth rate of approximately 1,000%. Therefore, because of these elements, the regional market will grow rapidly in the coming years.

Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Candela Corporation (Syneron Medical)
  • Bausch Health Companies, Inc.
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • AbbVie, Inc.
  • Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
  • Hologic, Inc.
  • Galderma S.A.
  • Zimmer MedizinSysteme GmbH
  • Endo International PLC
  • Merz Pharma GmbH & Co. KGaA

North America Cellulite Treatment Market Report Segmentation

By Gender

  • Female
  • Male

By Procedure Type

  • Non-invasive
  • Topical
  • Minimally Invasive

By Cellulite Type

  • Soft Cellulite
  • Hard Cellulite
  • Edematous

By End User

  • Clinics & Beauty Centers
  • Hospitals
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1North America Cellulite Treatment Market, by Gender
    • 1.4.2North America Cellulite Treatment Market, by Procedure Type
    • 1.4.3North America Cellulite Treatment Market, by Cellulite Type
    • 1.4.4North America Cellulite Treatment Market, by End User
    • 1.4.5North America Cellulite Treatment Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in Cellulite Treatment Market

Chapter 5.North America Cellulite Treatment Market by Gender

  • 5.1North America Female Market by Region
  • 5.2North America Male Market by Region

Chapter 6.North America Cellulite Treatment Market by Procedure Type

  • 6.1North America Non-invasive Market by Country
  • 6.2North America Topical Market by Country
  • 6.3North America Minimally Invasive Market by Country

Chapter 7.North America Cellulite Treatment Market by Cellulite Type

  • 7.1North America Soft Cellulite Market by Country
  • 7.2North America Hard Cellulite Market by Country
  • 7.3North America Edematous Market by Country

Chapter 8.North America Cellulite Treatment Market by End User

  • 8.1North America Clinics & Beauty Centers Market by Country
  • 8.2North America Hospitals Market by Country
  • 8.3North America Others Market by Country

Chapter 9.North America Cellulite Treatment Market by Country

  • 9.1US Cellulite Treatment Market
    • 9.1.1US Cellulite Treatment Market by Gender
    • 9.1.2US Cellulite Treatment Market by Procedure Type
    • 9.1.3US Cellulite Treatment Market by Cellulite Type
    • 9.1.4US Cellulite Treatment Market by End User
  • 9.2Canada Cellulite Treatment Market
    • 9.2.1Canada Cellulite Treatment Market by Gender
    • 9.2.2Canada Cellulite Treatment Market by Procedure Type
    • 9.2.3Canada Cellulite Treatment Market by Cellulite Type
    • 9.2.4Canada Cellulite Treatment Market by End User
  • 9.3Mexico Cellulite Treatment Market
    • 9.3.1Mexico Cellulite Treatment Market by Gender
    • 9.3.2Mexico Cellulite Treatment Market by Procedure Type
    • 9.3.3Mexico Cellulite Treatment Market by Cellulite Type
    • 9.3.4Mexico Cellulite Treatment Market by End User
  • 9.4Rest of North America Cellulite Treatment Market
    • 9.4.1Rest of North America Cellulite Treatment Market by Gender
    • 9.4.2Rest of North America Cellulite Treatment Market by Procedure Type
    • 9.4.3Rest of North America Cellulite Treatment Market by Cellulite Type
    • 9.4.4Rest of North America Cellulite Treatment Market by End User

Chapter 10.Company Profiles

  • 10.1Candela corporation (Syneron Medical)
    • 10.1.1Company Overview
    • 10.1.2Recent strategies and developments:
      • 10.1.2.1Partnerships, Collaborations, and Agreements:
      • 10.1.2.2Product Launches and Product Expansions:
    • 10.1.3SWOT Analysis
  • 10.2Bausch Health Companies, Inc
    • 10.2.1Company Overview
    • 10.2.2Financial Analysis
    • 10.2.3Segmental and Regional Analysis
    • 10.2.4Research & Development Expense
    • 10.2.5Recent strategies and developments:
      • 10.2.5.1Trials and Approvals:
    • 10.2.6SWOT Analysis
  • 10.3Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
    • 10.3.1Company Overview
    • 10.3.2Recent strategies and developments:
      • 10.3.2.1Partnerships, Collaborations, and Agreements:
      • 10.3.2.2Product Launches and Product Expansions:
    • 10.3.3SWOT Analysis
  • 10.4AbbVie, Inc.
    • 10.4.1Company Overview
    • 10.4.2Financial Analysis
    • 10.4.3Regional Analysis
    • 10.4.4Research & Development Expense
    • 10.4.5Recent strategies and developments:
      • 10.4.5.1Product Launches and Product Expansions:
      • 10.4.5.2Acquisition and Mergers:
    • 10.4.6SWOT Analysis
  • 10.5Hologic, Inc.
    • 10.5.1Company Overview
    • 10.5.2Financial Analysis
    • 10.5.3Segmental and Regional Analysis
    • 10.5.4Research & Development Expenses
    • 10.5.5SWOT Analysis
  • 10.6Galderma S.A.
    • 10.6.1Company Overview
    • 10.6.2SWOT Analysis
  • 10.7Endo International PLC
    • 10.7.1Company Overview
    • 10.7.2Financial Analysis
    • 10.7.3Segmental Analysis
    • 10.7.4Research & Development Expense
    • 10.7.5Recent strategies and developments:
      • 10.7.5.1Trials and Approvals:
      • 10.7.5.2Acquisition and Mergers:
    • 10.7.6SWOT Analysis
  • 10.8Merz Pharma GmbH & Co. KGaA
    • 10.8.1Company Overview
    • 10.8.2SWOT Analysis
  • 10.9Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
    • 10.9.1Company Overview
    • 10.9.2SWOT Analysis
  • 10.10.Zimmer MedizinSysteme GmbH
    • 10.10.1Company Overview
    • 10.10.2SWOT Analysis

LIST OF TABLES

  • TABLE 1North America Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 2North America Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 3North America Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 4North America Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 5North America Female Market by Region, 2020 - 2023, USD Million
  • TABLE 6North America Female Market by Region, 2024 - 2031, USD Million
  • TABLE 7North America Male Market by Region, 2020 - 2023, USD Million
  • TABLE 8North America Male Market by Region, 2024 - 2031, USD Million
  • TABLE 9North America Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 10North America Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 11North America Non-invasive Market by Country, 2020 - 2023, USD Million
  • TABLE 12North America Non-invasive Market by Country, 2024 - 2031, USD Million
  • TABLE 13North America Topical Market by Country, 2020 - 2023, USD Million
  • TABLE 14North America Topical Market by Country, 2024 - 2031, USD Million
  • TABLE 15North America Minimally Invasive Market by Country, 2020 - 2023, USD Million
  • TABLE 16North America Minimally Invasive Market by Country, 2024 - 2031, USD Million
  • TABLE 17North America Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 18North America Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 19North America Soft Cellulite Market by Country, 2020 - 2023, USD Million
  • TABLE 20North America Soft Cellulite Market by Country, 2024 - 2031, USD Million
  • TABLE 21North America Hard Cellulite Market by Country, 2020 - 2023, USD Million
  • TABLE 22North America Hard Cellulite Market by Country, 2024 - 2031, USD Million
  • TABLE 23North America Edematous Market by Country, 2020 - 2023, USD Million
  • TABLE 24North America Edematous Market by Country, 2024 - 2031, USD Million
  • TABLE 25North America Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 26North America Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 27North America Clinics & Beauty Centers Market by Country, 2020 - 2023, USD Million
  • TABLE 28North America Clinics & Beauty Centers Market by Country, 2024 - 2031, USD Million
  • TABLE 29North America Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 30North America Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 31North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 32North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 33North America Cellulite Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 34North America Cellulite Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 35US Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 36US Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 37US Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 38US Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 39US Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 40US Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 41US Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 42US Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 43US Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 44US Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 45Canada Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 46Canada Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 47Canada Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 48Canada Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 49Canada Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 50Canada Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 51Canada Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 52Canada Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 53Canada Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 54Canada Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 55Mexico Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 56Mexico Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 57Mexico Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 58Mexico Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 59Mexico Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 60Mexico Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 61Mexico Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 62Mexico Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 63Mexico Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 64Mexico Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 65Rest of North America Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 66Rest of North America Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 67Rest of North America Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 68Rest of North America Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 69Rest of North America Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 70Rest of North America Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 71Rest of North America Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 72Rest of North America Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 73Rest of North America Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 74Rest of North America Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 75Key Information - candela corporation
  • TABLE 76key information - Bausch Health Companies, Inc.
  • TABLE 77Key Information - Sinclair Pharma Ltd.
  • TABLE 78Key information - AbbVie, Inc.
  • TABLE 79Key Information - Hologic, Inc.
  • TABLE 80Key Information - Galderma S.A.
  • TABLE 81Key Information - Endo International PLC
  • TABLE 82Key information - Merz Pharma GmbH & Co. KGaA
  • TABLE 83Key Information - Cynosure, LLC
  • TABLE 84Key Information - Zimmer MedizinSysteme GmbH
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!